Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | CA4 | P22748 | 1/20 | 0.31 |
| ▸ | CA6 | P23280 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | RECQL | P46063 | 1/20 | 0.31 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8852271 | 0.70 | — | — | |
| Perbromobenzene SCHEMBL27124 | 0.67 | ALDH1A1 (0.50) | CA1CA2CA4CA6ALDH1A1 | |
| SCHEMBL8852304 | 0.67 | — | — | |
| SCHEMBL22802565 | 0.67 | CA1 (0.35) | CA1CA2CA4CA6ALDH1A1 | |
| SCHEMBL17061062 | 0.62 | — | — | |
| SCHEMBL8852575 | 0.62 | — | — | |
| Pentabromophenol SCHEMBL9805044 | 0.55 | CA1 (0.31) | CA1CA2CA4CA6ALDH1A1 | |
| SCHEMBL2517217 | 0.55 | CA1 (0.31) | CA1CA2CA4CA6ALDH1A1 | |
| Pentabromophenol SCHEMBL11517668 | 0.55 | CA1 (0.31) | CA1CA2CA4CA6ALDH1A1 | |
| SCHEMBL11881165 | 0.53 | TSHR (0.44) | CA1CA2CA4CA6ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 86 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7951743-B2 | Preparation of ultra high molecular weight linear low density polyethylene | EQUISTAR CHEMICALS, LP (US) | 2011-05-31 | — | — | US | claimed |
| US-7429635-B2 | Preparation of ultra high molecular weight linear low density polyethylene | EQUISTAR CHEMICALS, LP (US) | 2008-09-30 | — | — | US | claimed |
| WO-2008042059-A1 | PREPARATION OF ULTRA HIGH MOLECULAR WEIGHT LINEAR LOW DENSITY POLYETHYLENE | EQUISTAR CHEMICALS, LP (US) | 2008-04-10 | — | — | WO | claimed |
| US-20080081887-A1 | Preparation of ultra high molecular weight linear low density polyethylene | EQUISTAR CHEMICALS, LP | 2008-04-03 | — | — | US | claimed |
| US-7094723-B2 | Catalysts containing at least one heterocyclic ligand for improving the catalysts' performance of olefin polymerization | EQUISTAR CHEMICALS LP (US) | 2006-08-22 | — | — | US | claimed |
| US-6998363-B2 | Polyolefin catalyst component using non-covalent interactions | THE UNIVERSITY OF HONG KONG (HK) | 2006-02-14 | — | — | US | claimed |
| US-20040248728-A1 | Polyolefin catalyst component using non-covalent interactions | HONG KONG, UNIVERSITY OF, THE (HK) | 2004-12-09 | — | — | US | claimed |
| WO-2004016627-A1 | POLYOLEFIN CATALYST COMPONENT USING NON-COVALENT INTERACTIONS | THE UNIVERSITY OF HONG KONG (CN) | 2004-02-26 | — | — | WO | claimed |
| US-20030203807-A1 | Catalysts containing at least one heterocyclic ligand for improving the catalysts' performance of olefin polymerization | EQUISTAR CHEMICALS L.P. | 2003-10-30 | — | — | US | claimed |
| CN-118055858-B | Reinforced polypropylene composition | 巴塞尔聚烯烃股份有限公司 | 2025-04-01 | — | — | CN | disclosed |
| US-20250011483-A1 | REINFORCED POLYPROPYLENE COMPOSITION | BASELL POLYOLEFINE GMBH (DE) | 2025-01-09 | — | — | US | disclosed |
| US-12187877-B2 | Extrusion additive manufacturing process for producing polyethylene articles | BASELL POLYOLEFINE GMBH (DE) | 2025-01-07 | — | — | US | disclosed |
| EP-3927522-B1 | EXTRUSION ADDITIVE MANUFACTURING PROCESS FOR PRODUCING POLYETHYLENE ARTICLES | BASELL POLYOLEFINE GMBH (DE) | 2024-12-11 | — | — | EP | disclosed |
| CN-118055858-A | Reinforced polypropylene composition | 巴塞尔聚烯烃股份有限公司 | 2024-05-17 | — | — | CN | disclosed |
| US-6180552-B1 | OLEFIN POLYMERIZATION COORDINATION CATALYSTS | EQUISTAR CHEMICALS, L.P. | 2001-01-30 | — | — | US | disclosed |
| WO-2000059914-A1 | METAL COMPOUNDS CONTAINING NEUTRAL, MULTIDENTATE AZACYCLIC LIGANDS, CATALYSTS USING THEM, OLEFIN POLYMERIZATION METHODS USING THEM | EQUISTAR CHEMICALS, L.P. (US) | 2000-10-12 | — | — | WO | disclosed |
| US-6127484-A | POLYMERIZING AN OLEFIN IN A FIRST ZONE WITH A SINGLE-SITE CATALYST IN THE PRESENCE OF A NON-ALUMOXANE ACTIVATOR TO PRODUCE FIRST POLYMER, TRANSFERRING IT TO A SECOND ZONE WITH ADDITIONAL OLEFIN WITH ZIEGLER NATTA CATALYST ZIEGLER NATTA | EQUISTAR CHEMICALS, LP (US) | 2000-10-03 | — | — | US | disclosed |
| US-6020493-A | Single-site catalyst preparation | EQUISTAR CHEMICALS, LP (US) | 2000-02-01 | — | — | US | disclosed |
| US-5594079-A | COORDINATION CATALYST CONTAINING BORON, STEREOREGULAR POLYPROPYLENE | TOSOH CORPORATION (JP) | 1997-01-14 | — | — | US | disclosed |
| EP-0582278-A2 | Method for producing a polyolefin | TOSOH CORPORATION (JP) | 1994-02-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030203807-A1 | Catalysts containing at least one heterocyclic ligand for improving the catalysts' performance of olefin polymerization | NCL, NOXO1, FIS1 | CA1 1575/4885CA2 1383/4885CA4 480/4885 |
| US-20040248728-A1 | Polyolefin catalyst component using non-covalent interactions | TCP1, CCT7, AP1M1 | CA1 3696/4885CA2 4726/4885CA4 4016/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.